Test investor 4
PE / VC
2022
$8 890 M
Almaty, Kazakhstan
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Testing Investor 1 is a forward-thinking private equity firm dedicated to identifying and unlocking value in dynamic, high-potential businesses. We focus on partnering with innovative companies across technology, renewable energy, healthcare, and consumer sectors, providing them with the capital and strategic support needed to scale and thrive.
At Testing Investor 1, we prioritize long-term growth and sustainability, leveraging our deep industry expertise and extensive network to drive transformational results. Our team collaborates closely with management to refine operations, expand market reach, and optimize financial performance, ensuring mutual success for our partners and investors alike.
Founded on the principles of integrity, adaptability, and innovation, Testing Investor 1 remains committed to delivering exceptional returns while fostering positive economic and social impact in every investment we make.
Industry
Region of investment
Test investor 4 Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Test fund 1
|
Private Equity (PE)
|
Consumer Services (B2C)
Fashion/Beauty
Financial Services
|
Series B
|
Australia and others
|
$10-50 m
|
—
|
November 2024
|
|
Test fund 2
|
Venture Capital (VC)
|
E-commerce/Marketplace
Healthcare Services
|
Late Stage (Series C+)
|
Europe
|
$10-50 m
|
$1234 M
|
March 2024
|
|
Test fund 3
|
Venture Capital (VC)
|
Cannabis
PropTech / ConTech
|
Seed
Late Stage (Series C+)
|
Middle East
|
$100+ m
|
$123456 M
|
December 2024
|
